Updates to Commercialization Plan Sample Clauses
Updates to Commercialization Plan. On an annual basis no later than September 30th of each year (except as set forth in Section 6.2.1), Pfizer shall create and submit to the JSC for its review and discussion of the Commercialization Plan for the following calendar year. Each Commercialization Plan shall contain a five (5) year rolling annual plan for the Commercialization of the Product in the Territory for use in the Field. The first year of such plan (except the initial Commercialization Plan as set forth in Section 6.2.1), shall constitute the plan and budget for the first year and the remaining four (4) years shall be for planning purposes only (provided that Pfizer shall prepare such four (4) year portion in accordance with its good faith anticipated activities). Upon review and discussion by the JSC, Pfizer shall finalize the Commercialization Plan for the following calendar year. From time to time during a given calendar year, Pfizer may propose written updates to the Commercialization Plan for review and discussion by the JSC. Pfizer shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.
Updates to Commercialization Plan. The Commercialization Plan for the Territory shall be updated or amended by the JCC on an annual basis, or more frequently as necessary, including promptly after Orexigen exercises its right to Co-Promote pursuant to Section 3.5. Updates and amendments to the Commercialization Plan shall be subject to the approval of the JSC pursuant to Section 5.1.2(c), and, if Orexigen exercises its right to Co-Promote, made in accordance with the last sentence in Sections 3.2.1 and 3.
Updates to Commercialization Plan. Each Commercialization Plan for each country in the Territory shall be updated or amended by the JCC on an annual basis, or more frequently as necessary, including promptly after Orexigen exercises its right to Co-Promote pursuant to Section 3.5. Updates and amendments to the Commercialization Plan shall be subject to the approval of the JSC pursuant to Section 5.1.2(c), and, if Orexigen exercises its right to Co-Promote, made in accordance with the last sentence in Sections 3.2.1. and 3.2.3. Each Calendar Year the JCC will prepare an update to the Commercialization Plan, and submit it in advance to the JSC in order to obtain approval from the JSC no later than [***].
Updates to Commercialization Plan. On an annual basis no later than November 30 of each year (except as set forth in Section 6.2.1), Asahi shall create and submit to the JSC for its review and discussion the Commercialization Plan for the following calendar year. The Commercialization Plan shall contain a five (5) year rolling annual plan for the Commercialization of the Product in the Territory for use in the Field. The first year of such plan (except the initial Commercialization Plan as set forth in Section 6.2.1), shall constitute the plan and budget for the first year and the remaining four (4) years shall be for planning purposes only (provided that Asahi shall prepare such four (4) year portion in accordance with its good faith anticipated activities). Upon review and discussion by the JSC, Asahi shall finalize the Commercialization Plan for the following calendar year. From time to time during a given calendar year, Asahi may propose written updates to the Commercialization Plan for review and discussion by the JSC. Asahi shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.
Updates to Commercialization Plan. Following the creation of the Initial Commercialization Plan in accordance with Section 6.2.1 above [***]. Licensee shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.
Updates to Commercialization Plan. On an annual basis no later than October 15 of each Calendar Year (except as set forth in Section 6.2.1), Licensee shall create and submit to the JCSC for its review, discussion and approval the Commercialization Plan for the following Calendar Year. From time to time during a given Calendar Year, Licensee may propose written updates to the Commercialization Plan for review, discussion and approval by the JCSC. Licensee shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement.
Updates to Commercialization Plan. During the CP Period, no later than March 31 of each AKP Fiscal Year (except as set forth in Section 7.2.1), AKP shall create and submit to the JSC for review the Commercialization Plan for the following Commercialization Plan Period.
Updates to Commercialization Plan. [***] each Calendar Year (except as set forth in Section 6.2.1), Licensee shall create and submit to the JCC for its review, discussion and approval the Commercialization Plan for the following Calendar Year. From time to time during a given Calendar Year, Licensee may propose written updates to the Commercialization Plan for review, discussion and approval by the JCC. Licensee shall conduct all Commercialization of the Product in accordance with the Commercialization Plan and this Agreement. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934.